Rentokil Initial (LON:RTO) had its target price upped by Deutsche Bank from GBX 325 ($4.25) to GBX 420 ($5.49) in a research report released on Wednesday morning, ThisIsMoney.Co.Uk reports. Deutsche Bank currently has a hold rating on the stock.

RTO has been the topic of a number of other research reports. Barclays set a $14.00 price objective on Coty and gave the stock a hold rating in a research note on Thursday, June 27th. JPMorgan Chase & Co. restated a neutral rating on shares of Anglo American in a research note on Wednesday, May 15th. Jefferies Financial Group restated a hold rating on shares of COMPASS GRP PLC/S in a research note on Tuesday, April 9th. Finally, Peel Hunt lowered their price objective on Abcam from GBX 1,550 ($20.25) to GBX 1,430 ($18.69) and set an add rating on the stock in a research note on Monday, July 22nd. Five research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Rentokil Initial currently has a consensus rating of Hold and a consensus target price of GBX 393.71 ($5.14).

Rentokil Initial stock opened at GBX 411.60 ($5.38) on Wednesday. The business’s fifty day moving average is GBX 402.67. Rentokil Initial has a one year low of GBX 280 ($3.66) and a one year high of GBX 429.40 ($5.61). The company has a debt-to-equity ratio of 152.01, a quick ratio of 0.72 and a current ratio of 0.88. The company has a market cap of $7.61 billion and a price-to-earnings ratio of -77.66.

Rentokil Initial Company Profile

Rentokil Initial plc, through its subsidiaries, provides route-based services in North America, the United Kingdom, Europe, Asia, Pacific, and rest of world. It offers a range of pest control services from rodents to flying insects, as well as to other forms of wildlife management for commercial and residential customers.

Further Reading: What is quantitative easing?

Analyst Recommendations for Rentokil Initial (LON:RTO)

Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with's FREE daily email newsletter.